Luciana Gavernet
Orcid: 0000-0001-9285-3788
According to our database1,
Luciana Gavernet
authored at least 9 papers
between 2010 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
Online presence:
-
on orcid.org
On csauthors.net:
Bibliography
2023
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity.
J. Chem. Inf. Model., November, 2023
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity.
J. Comput. Aided Mol. Des., February, 2023
2022
Novel Dimeric hHv1 Model and Structural Bioinformatic Analysis Reveal an ATP-Binding Site Resulting in a Channel Activating Effect.
J. Chem. Inf. Model., 2022
Structure-Based Virtual Screening Identifies Novobiocin, Montelukast, and Cinnarizine as TRPV1 Modulators with Anticonvulsant Activity <i>In Vivo</i>.
J. Chem. Inf. Model., 2022
Identification of New Carbonic Anhydrase VII Inhibitors by Structure-Based Virtual Screening.
J. Chem. Inf. Model., 2022
2021
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study.
J. Chem. Inf. Model., 2021
2018
Searching for New Leads To Treat Epilepsy: Target-Based Virtual Screening for the Discovery of Anticonvulsant Agents.
J. Chem. Inf. Model., 2018
2012
Several New Diverse Anticonvulsant Agents Discovered in a Virtual Screening Campaign Aimed at Novel Antiepileptic Drugs to Treat Refractory Epilepsy.
J. Chem. Inf. Model., 2012
2010
Affinity of Sulfamates and Sulfamides to Carbonic Anhydrase II Isoform: Experimental and Molecular Modeling Approaches.
J. Chem. Inf. Model., 2010